Table 1.
Characteristic | Cases |
Controls |
p-value | ||
---|---|---|---|---|---|
n | % | n | % | ||
Age | |||||
Younger (20–23 years) | 40 | 53.3 | 39 | 52.0 | 0.87 |
Older (24–35 years) | 35 | 46.7 | 36 | 48.0 | |
Gender | |||||
Male | 50 | 66.7 | 50 | 66.7 | 1.00 |
Female | 25 | 33.3 | 25 | 33.3 | |
Race | |||||
White | 60 | 80.0 | 60 | 80.0 | 1.00 |
Black | 15 | 20.0 | 15 | 20.0 | |
Deployment length | |||||
Short (6 to <12 months) | 55 | 73.0 | 57 | 76.0 | 0.71 |
Long (12–18 months) | 20 | 27.0 | 18 | 24.0 | |
Time between deployment end and postdeployment serum sample draw | |||||
≤7 days | 42 | 56.0 | 38 | 50.7 | 0.51 |
>7 days | 33 | 44.0 | 7 | 49.3 | |
Time between predeployment serum draw and start of deployment | |||||
≤90 days | 52 | 69.3 | 46 | 61.3 | 0.30 |
>90 days | 23 | 30.7 | 29 | 38.7 |